Suchergebnisse - "Enomoto, Takayuki"

PubPharm (28)

1

Homologous recombination inquiry through ovarian malignancy investigations : JGOG3025 Study

enthalten in: Cancer science | 2023

von Yoshihara, K. | Baba, T. | Tokunaga, H. | +14

2

Trends and characteristics of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer in Japan : a survey by the Gynecologic Oncology Committee of the Japan Society of Obstetrics and Gynecology

enthalten in: Journal of gynecologic oncology | 2023

von Ushijima, K. | Tsuda, N. | Yamagami, W. | +4

3

Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer

enthalten in: Cancer science | 2023

von Oda, K. | Aoki, D. | Tsuda, H. | +5

4

The efficacy of human papillomavirus vaccination in young Japanese girls : the interim results of the OCEAN study

enthalten in: Human vaccines & immunotherapeutics | 2022

von Hiramatsu, K. | Ueda, Y. | Yagi, A. | +26

5

Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer : An open-label multicenter phase II trial (JGOG1079)

enthalten in: Gynecologic oncology | 2022

von Tanigawa, T. | Takeshima, N. | Ishikawa, H. | +21

6

Discrepancies in pathological diagnosis of endometrial stromal sarcoma : a multi-institutional retrospective study from the Japanese clinical oncology group

enthalten in: Human pathology | 2022

von Yoshida, H. | Kikuchi, A. | Tsuda, H. | +21

7

Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer

enthalten in: The New England journal of medicine | 2022

von Makker, V. | Colombo, N. | Casado Herráez, A. | +122

CommentIn: Nat Rev Clin Oncol. 2022 Mar;19(3):149. - PMID 35087212

8

Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab : The Japanese Gynecologic Oncology Group study JGOG3023

enthalten in: Cancer science | 2022

von Shoji, T. | Enomoto, T. | Abe, M. | +10

9

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer : Open-Label, Randomized Trial in Japan (NINJA)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Hamanishi, J. | Takeshima, N. | Katsumata, N. | +39

CommentIn: J Clin Oncol. 2021 Nov 20;39(33):3651-3655. - PMID 34529504

10

A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan

enthalten in: Cancer science | 2021

von Yagi, A. | Ueda, Y. | Nakagawa, S. | +10